Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krumholz

Showing results (611-620 of 1,576) with videos related to

Pageof 158
Sort By:
Journal of the American College of Cardiology|December 16, 2017
Data Sharing and Cardiology: Platforms and PossibilitiesPranammya Dey, Joseph S Ross, Jessica D Ritchie, et al.
Annals of Internal Medicine|November 8, 2006
The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screeningCary P Gross, Gail J McAvay, Harlan M Krumholz, et al.
Biomolecules|April 23, 2022
Enhancement of Methane Catalysis Rates in <i>Methylosinus trichosporium</i> OB3bDipayan Samanta, Tanvi Govil, Priya Saxena, et al.
JACC. Heart Failure|March 14, 2014
Patterns of change in nesiritide use in patients with heart failure: how hospitals react to new informationChohreh Partovian, Shu-Xia Li, Xiao Xu, et al.
Journal of the American Heart Association|March 23, 2017
Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990-2011Behnood Bikdeli, Natdanai Punnanithinont, Yasir Akram, et al.
Annals of Neurology|July 1, 1983
Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptineJ E Granato, B J Stern, A Ringel, et al.
Clinical Trials (London, England)|August 26, 2020
Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trialsBehnood Bikdeli, César Caraballo, John Welsh, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 21, 2025
Hypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID-19 PandemicMohammed Essa, Devesh Malik, Yuan Lu, et al.
JAMA Network Open|April 22, 2020
Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017Audrey D Zhang, Jeremy Puthumana, Nicholas S Downing, et al.
Journal of General Internal Medicine|October 27, 2019
Patient-Reported Quality of Hospital Discharge Transitions: Results from the SILVER-AMI StudyBradley G Richards, Alexandra M Hajduk, Julia Perry, et al.
Pageof 158

Showing results (611-620 of 1,576) with videos related to

Sort By:
Pageof 158
Journal of the American College of Cardiology|December 16, 2017
Data Sharing and Cardiology: Platforms and PossibilitiesPranammya Dey, Joseph S Ross, Jessica D Ritchie, et al.
Annals of Internal Medicine|November 8, 2006
The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screeningCary P Gross, Gail J McAvay, Harlan M Krumholz, et al.
Biomolecules|April 23, 2022
Enhancement of Methane Catalysis Rates in <i>Methylosinus trichosporium</i> OB3bDipayan Samanta, Tanvi Govil, Priya Saxena, et al.
JACC. Heart Failure|March 14, 2014
Patterns of change in nesiritide use in patients with heart failure: how hospitals react to new informationChohreh Partovian, Shu-Xia Li, Xiao Xu, et al.
Journal of the American Heart Association|March 23, 2017
Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990-2011Behnood Bikdeli, Natdanai Punnanithinont, Yasir Akram, et al.
Annals of Neurology|July 1, 1983
Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptineJ E Granato, B J Stern, A Ringel, et al.
Clinical Trials (London, England)|August 26, 2020
Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trialsBehnood Bikdeli, César Caraballo, John Welsh, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 21, 2025
Hypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID-19 PandemicMohammed Essa, Devesh Malik, Yuan Lu, et al.
JAMA Network Open|April 22, 2020
Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017Audrey D Zhang, Jeremy Puthumana, Nicholas S Downing, et al.
Journal of General Internal Medicine|October 27, 2019
Patient-Reported Quality of Hospital Discharge Transitions: Results from the SILVER-AMI StudyBradley G Richards, Alexandra M Hajduk, Julia Perry, et al.
Pageof 158